SmartCella tecknar licensavtal för Extroducer® med HeartWorks för precis leverans av cellterapier
SmartCella signs Extroducer® license agreement with HeartWorks for precise delivery of cell therapies
Reflections from Meeting on the Mesa in Phoenix, US: Getting CAR-T to the tumor
Extroducer® 2.0 får 510(k)-godkännande från amerikanska FDA
The Extroducer® 2.0 receives 510(k) clearance by the US FDA
SmartCella expands patent for the Extroducer® into the US and Japan
SmartCella utökar patentskyddet för Extroducer® till USA och Japan
Academic program licensing agreement signed with University Medical Centre Ljubljana
Extroducer® data for intramyocardial delivery presented at EuroPCR 2026 in Paris
SmartCella and Heqet Therapeutics enter into licensing agreement regarding the Extroducer® delivery platform

Let’s pioneer the future of targeted therapies together